Athersys

Athersys Employees

Delisted

The The number of employees of Athersys (ATHX) as of Nov 20, 2026 is 83. In the previous year, The number of employees was 83.00 — a change of 0.00% (lower).

Employees

83

YoY

0.00%

Last updated:

In 2023, Athersys employed 83 people, a 0.00% change from the 83.00 number of employees in the previous year.

The Athersys Employees history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Employees
Date
Employees
Jan 1, 2016
83.00 USD
Jan 1, 2017
83.00 USD
Jan 1, 2018
83.00 USD
Jan 1, 2019
83.00 USD
Jan 1, 2020
83.00 USD
Jan 1, 2021
83.00 USD
Jan 1, 2022
83.00 USD
Jan 1, 2023
83.00 USD
The Athersys Employees history
YEAREmployeesYoY
830.00%
830.00%
830.00%
830.00%
830.00%
830.00%
830.00%
830.00%
830.00%
83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Athersys Stock analysis

What does Athersys do? Athersys Inc. is a biopharmaceutical company based in Cleveland, Ohio. It was founded in 1995 and focuses on the discovery, development, and commercialization of regenerative therapies and cell therapies. The idea for founding Athersys Inc. came from the vision that stem cell therapies could change the way we treat diseases. In the early stages of the company, the team focused on isolating and characterizing human stem cells. Over time, the research evolved and Athersys Inc. shifted its focus to developing drugs that promote tissue and organ regeneration. Athersys Inc.'s business model involves developing stem cell-based medications that are tested in clinical trials. The goal is to combat diseases such as stroke, heart attack, inflammatory diseases, and respiratory syndromes. Athersys Inc. utilizes a proprietary technology platform called MultiStem to isolate, expand, and differentiate stem cells. The company works closely with clinical partners in the pharmaceutical and biotech industry to conduct clinical trials and bring medications to market. Athersys has four divisions: Hematology, Neurology, Pulmonology, and Cardiology. In hematology, Athersys focuses on developing a therapy for cancer treatment. By administering MultiStem, a type of stem cell therapy, they hope to reduce the side effects of chemotherapy and kill cancer cells. In neurology, Athersys focuses on developing medications for the treatment of strokes and neurological disorders. The goal is to trigger regenerative processes in the brain and promote the growth of nerve cells and the regeneration of brain tissue. In pulmonology, Athersys focuses on developing therapies for the treatment of lung diseases such as ARDS and COPD. In cardiology, Athersys aims to improve the healing process after a heart attack by supporting the natural regeneration process of the heart muscle. Athersys' products are still in development and are in various stages of clinical trials. The most well-known product of Athersys is the MultiStem product. The company utilizes its proprietary technology platform to isolate and expand stem cells from human bone marrow and adipose tissue. MultiStem is intended to promote tissue regeneration and reduce inflammation. It has been tested in various preclinical and clinical trials and has shown promising results. Overall, Athersys Inc. is a company that focuses on regenerative therapies and cell therapies. By utilizing its proprietary technology platform MultiStem, Athersys hopes to develop stem cell-based therapies that can contribute to the cure of many different diseases. Although the company is still in the development and study phase, Athersys has already made impressive progress and remains an important player in the biopharmaceutical industry. Athersys is one of the most popular companies on Eulerpool.

Employees Details

Examining Athersys's Employee Base

Athersys's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Athersys's operational capacity and future potential.

Year-to-Year Comparison

Assessing Athersys's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Athersys's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Athersys’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Athersys stock

The number of employees of Athersys is 83 in 2023.

The number of employees of Athersys changed from 83.00 to 83, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of employees Athersys since 2006 – with annual values, charts, and detailed analysis.

The number of employees describes the number of people directly employed by the company.

The number of employees's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The number of employees's Athersys historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Athersys

All Key Metrics — Athersys